In a prospective study of street-recruited intravenous drug users (IVDUs) in Miami, Florida,
USA, 107 (46· 5%) of 230 IVDUs were infected with HIV-1. Of these HIV-1 seropositive …

Seroprevalence of human immunodeficiency virus type 1 (HIV-1) and human T lymphotropic
virus types I and II (HTLV-I/II) was determined among 1160 intravenous (iv) drug abusers …

Data from a continuing multiyear seroprevalence survey of human T-lymphotropic virus
types I or II (HTLV-I/II) among intravenous drug users in seven US locations were analyzed …

Human T-cell lymphotropic virus (HTLV) type II has spread among intravenous drug users
(IDUs), many of whom are coinfected with HIV-1. We have investigated the rate of HTLV-II …

To identify risk factors for human T lymphotropic virus type II (HTLV-II) infection in
intravenous drug users (IVDUs), participants in a longitudinal study of human …

Seroprevalence of human T lymphotropic virus (HTLV) and human immunodeficiency virus
type 1 (HIV-1) was determined among 7841 intravenous drug users (IVDUs) from drug …

To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

Background Human T-lymphotropic virus type II (HTLV-II) is widespread among injecting
drug users (IDU) and may contribute to the risk of leukemia/lymphoma, neurodegenerative …

The clinical significance of human T-cell lymphotropic virus type II (HTLV-II) infection, unlike
that of HTLV-I, is unknown, and the major known association of HTLV-II seropositivity is with …

To determine whether human T-lymphotropic virus (HTLV) type II coinfection affects
progression of human immunodeficiency virus type 1 (HIV) infection, longitudinal data on …